35 results
8-K
EX-10.1
PSTX
Poseida Therapeutics Inc
7 Aug 23
Astellas and Poseida Therapeutics Announce Strategic
9:01am
insurers as may be necessary to continue its business.
2.17 Anti-Corruption Laws. Neither the Company nor any director or officer nor, to the knowledge … Act of 1977, as amended, the Bribery Act 2010 of the United Kingdom or any other applicable anti-bribery or anti-corruption law (collectively, the “Anti
8-K
EX-1.1
19qi5sa
4 Aug 22
Poseida Therapeutics Announces Proposed Public Offering of Common Stock
4:57pm
S-3
EX-1.2
0dmyqqjh
13 Aug 21
Shelf registration
4:13pm
10-K
8weudgq6z3
11 Mar 21
Annual report
4:11pm
10-Q
t1qvpn
20 Aug 20
Quarterly report
4:13pm
424B4
ddy 5ge74j7uj7
10 Jul 20
Prospectus supplement with pricing info
4:55pm